Cognito Therapeutics today announced new exploratory biomarker data supporting the use of its Spectris neuromodulation system. The company shared findings that highlighted a potential biological mechanism underlying the investigational Spectris platform at the Alzheimer’s Association International Conference (AAIC) 2026. Investigators evaluated cerebrospinal fluid (CSF) proteomics findings from the Phase 2 FLICKER study evaluating daily Spectris […]
MassDevice Neurological Hub
MassDevice's Neurological Hub is your resource for the latest news in the neurological device space. Stay informed about the innovations and business news shaping the neurological industry.
🧠 Narrow your focus with these categories:
Neuromodulation/Neurostimulation | Bioelectronic Medicine | Pain Management | Brain-Computer Interfaces
Here are the top neurological device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ A Medtronic engineer shares lessons from the adaptive deep brain stimulation project
+ Analysts see $400B BCI opportunity
+ 7 neurotech companies you need to know
+ Brain breakthroughs: Aprinoia Therapeutics’ harnesses AI and strategic partnerships to propel neurodegenerative disease research
+ 7 brain-computer interface companies you need to know
+ Natalizumab and PML: The complex dance of benefit and risk for MS
Latest Neurological News
Zeta wins FDA clearance for TMS robotic stereotactic system
Zeta Surgical announced today that it received FDA 510(k) clearance for its TMS Robotic System as a stereotaxic instrument. Boston-based Zeta Surgical designed its robotic platform for transcranial magnetic stimulation (TMS). The non-invasive therapy primarily targets treatment-resistant depression, among other behavioral health conditions. Those include obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD) and addiction disorders. […]
Neuspera earns Medicare win for sacral neuromod
Neuspera Medical announced today that the Centers for Medicare & Medicaid Services (CMS) confirmed its SNM system’s billing code. CMS assigned the Neurspera SNM (sacral neuromodulation) system to payment level APC 5464 in the proposed CY 2027 Outpatient Prospective Payment System Rule. This provides the externally powered integrated SNM (iSNM) system the same Medicare payment […]
Penumbra enrolls first patient in distal acute stroke thrombectomy study
Penumbra (NYSE:PEN) announced today that it initiated the FORWARD study of its mechanical thrombectomy technology. Alameda, California-based Penumbra’s real-world, prospective, multi-center study will collect safety and efficacy data on mechanical thrombectomy. That includes computer-assisted vacuum thrombectomy (CAVT) and modulated aspiration in the management of acute ischemic stroke with distal occlusions. Dr. Keith Woodward, a neurointerventional […]
Paradromics has a new chief clinical officer as it advances BCI tech
Paradromics announced today that it appointed neurologist and clinical scientist Dr. William J. Marks as its new chief clinical officer. Marks brings nearly three decades of experience across clinical neuroscience, implantable medical devices, neuromodulation and digital health to the Austin, Texas-based brain-computer interface (BCI) developer. He joins Paradromics as the company advances the Connect-One early […]
Vivani to sell neurotech subsidiary Cortigent to ClearOne
Vivani Medical (Nasdaq:VANI) announced today that it entered into a definitive agreement to sell its Cortigent subsidiary to ClearOne. Alameda, California-based Vivani, which develops implantable drug delivery devices, inked the deal to sell the wholly owned subsidiary, setting it up to become a wholly owned subsidiary of ClearOne upon consummation. In connection with the transaction, […]
Aurenar gets FDA breakthrough nod for noninvasive neuromod tech
Aurenar announced today that it received FDA breakthrough device designation for its V-Link noninvasive neuromodulation system. The breakthrough nod enables the acceleration of the development, assessment and review of the technology for the reduction of cerebral vasospasm in in adults with aneurysmal subarachnoid hemorrhage (aSAH). The designation applies to the use of V-Link in adult […]
NeuroBell raises $5.5M for AI-powered neonatal brain monitor
NeuroBell announced today on LinkedIn that it has raised $5.5 million to accelerate the launch of its AI-powered neonatal brain monitor. LUNA, the company’s novel medical device platform, provides portable electroencephalogram (EEG) monitoring with automated neonatal seizure detection at the bedside. The battery-powered, WiFi-connected system features an eight-channel EEG amplifier and 10-20 EEG placement for […]
Zimmer Biomet to pay up to $140M for Iovera nerve therapy tech from Pacira BioSciences
Pacira BioSciences announced today that it agreed to divest its Iovera nerve therapy device to Zimmer Biomet (NYSE:ZBH). Zimmer Biomet agreed to pay $70 million upfront, with potential future revenue-based milestone payments totaling up to an additional $70 million up to and through Dec. 31, 2031, bringing the deal’s total value to up to $140 […]
Bioness wins FDA clearance for portable neurostimulator for stroke recovery
Bioness Medical announced today that it received FDA 510(k) clearance for its PoNS (portable neuromodulation stimulator) system. Clearance covers the treatment of dynamic gait deficit due to chronic stroke symptoms. It expands the indications for PoNS beyond the existing approval for multiple sclerosis (MS). The milestone comes just a few months after Bioness acquired the […]
Aleph Neuro launches with high-res brain images using Butterfly Network ultrasound
Butterfly Network (NYSE:BFLY) today shared the launch of Aleph Neuro, a non-invasive brain imaging company utilizing ultrasound. Aleph Neuro, a research lab, says it builds brain-computer interfaces (BCIs) for what it describes as “the telepathic future.” It says that it captured the highest-resolution 3D images of the brain taken from outside the skull with its […]
